You are here

BioNTech

BioNTech's OncoC4 partnership off to good start with mid-stage trial results

BioNTech's OncoC4 partnership off to good start with mid-stage trial results

Yahoo/Reuters

clinical trials

metastatic non-small cell lung cancer

Flag link:

ASCO puts spotlight on advancing antibody-drug conjugate pipeline

ASCO puts spotlight on advancing antibody-drug conjugate pipeline

BioPharma Dive

antibody-drug conjugate

Flag link:

CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South

CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South

Medical Marketing and Media

Flag link:

BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit

BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit

Yahoo/Reuters

pancreatic cancer

Flag link:

Biopharma Bets Big on Antibody-Drug Conjugates

Biopharma Bets Big on Antibody-Drug Conjugates

BioSpace

antibody-drug conjugate

Bristol Myers Squibb

Flag link:

Cash-rich BioNTech broadens scope as COVID shot sales slide

Cash-rich BioNTech broadens scope as COVID shot sales slide

Yahoo/Reuters

Flag link:

Poland takes its COVID-19 vaccine fight to Pfizer's shareholders, urging the company to be a good corporate citizen

Poland takes its COVID-19 vaccine fight to Pfizer's shareholders, urging the company to be a good corporate citizen

Fierce Pharma

Flag link:

Pfizer accused of Covid-19 vaccine patent infringement again, this time by Arbutus and Genevant

Pfizer accused of Covid-19 vaccine patent infringement again, this time by Arbutus and Genevant

Endpoints

Flag link:

BioNTech Adds Two ADCs in Second Deal in as Many Months

BioNTech Adds Two ADCs in Second Deal in as Many Months

BioSpace

antibody-drug conjugate

Duality Biologics

Flag link:

BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal

BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal

Reuters

drug development

Flag link:

BioNTech's COVID-19 vaccine revenue forecasts lower than expected

BioNTech's COVID-19 vaccine revenue forecasts lower than expected

Biopharma Reporter

Flag link:

BioNTech signs deal to co-develop OncoC4's cancer drug

BioNTech signs deal to co-develop OncoC4's cancer drug

Reuters

drug development

Flag link:

Pfizer (PFE) Gets FDA Nod for Bivalent COVID Shot in Young Children

Pfizer (PFE) Gets FDA Nod for Bivalent COVID Shot in Young Children

Yahoo/Zacks.com

bivalent boosters

Flag link:

Pfizer/BioNTech submit FDA application for Omicron-adapted booster for young children

Pfizer/BioNTech submit FDA application for Omicron-adapted booster for young children

PM Live

Flag link:

Pfizer and BioNTech file BLA for Omicron-targeting Covid-19 vaccine

Pfizer and BioNTech file BLA for Omicron-targeting Covid-19 vaccine

Endpoints

Flag link:

BioNTech touts differences with Moderna in race for cancer vaccines

BioNTech touts differences with Moderna in race for cancer vaccines

Endpoints

Moderna Therapeutics

cancer vaccines

Flag link:

Pfizer begins plan to challenge Shingrix with an mRNA vaccine

Pfizer begins plan to challenge Shingrix with an mRNA vaccine

BioPharma Dive

Flag link:

mRNA vaccines: Four major clinical trial readouts to watch in 2023

mRNA vaccines: Four major clinical trial readouts to watch in 2023

Clinical Trials Arena

clinical trials

Moderna Therapeutics

Flag link:

BioNTech completes first in-house plasmid DNA manufacturing facility

BioNTech completes first in-house plasmid DNA manufacturing facility

Biopharma Reporter

drug manufacturing

Flag link:

U.S. FDA, CDC see early signal of possible Pfizer bivalent COVID shot link to stroke

U.S. FDA, CDC see early signal of possible Pfizer bivalent COVID shot link to stroke

Yahoo/Reuters

bivalent boosters

Flag link:

Pages